Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75354363 | 7535436 | 3 | F | 20160721 | 20100810 | 20160729 | EXP | US-ELI_LILLY_AND_COMPANY-US201007007291 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160729 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75354363 | 7535436 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | 10 MG, DAILY (1/D) | Y | U | 20592 | 10 | MG | TABLET | QD | |||||
| 75354363 | 7535436 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | 15 MG, DAILY (1/D) | Y | U | 20592 | 15 | MG | TABLET | QD | |||||
| 75354363 | 7535436 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 20 MG, QD | Y | U | 20592 | 20 | MG | TABLET | QD | ||||
| 75354363 | 7535436 | 4 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | UNK, UNKNOWN | Y | U | 20592 | TABLET | |||||||
| 75354363 | 7535436 | 5 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | U | 0 | |||||||||||
| 75354363 | 7535436 | 6 | C | IBUPROFEN. | IBUPROFEN | 1 | U | 0 | |||||||||||
| 75354363 | 7535436 | 7 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | U | 0 | |||||||||||
| 75354363 | 7535436 | 8 | C | RANITIDINE. | RANITIDINE | 1 | U | 0 | |||||||||||
| 75354363 | 7535436 | 9 | C | IRON | IRON | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 75354363 | 7535436 | 1 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 75354363 | 7535436 | HO |
| 75354363 | 7535436 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 75354363 | 7535436 | Abasia | |
| 75354363 | 7535436 | Asthenia | |
| 75354363 | 7535436 | Blister | |
| 75354363 | 7535436 | Blood glucose increased | |
| 75354363 | 7535436 | Brain neoplasm | |
| 75354363 | 7535436 | Diabetes mellitus | |
| 75354363 | 7535436 | Dizziness | |
| 75354363 | 7535436 | Drug dose omission | |
| 75354363 | 7535436 | Dysmenorrhoea | |
| 75354363 | 7535436 | Dysuria | |
| 75354363 | 7535436 | Feeding disorder | |
| 75354363 | 7535436 | Headache | |
| 75354363 | 7535436 | Insomnia | |
| 75354363 | 7535436 | Menorrhagia | |
| 75354363 | 7535436 | Pain | |
| 75354363 | 7535436 | Peripheral swelling | |
| 75354363 | 7535436 | Pollakiuria | |
| 75354363 | 7535436 | Thirst | |
| 75354363 | 7535436 | Vision blurred | |
| 75354363 | 7535436 | Weight decreased | |
| 75354363 | 7535436 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |